Aspirin has been proposed as a treatment for COVID-19 on the basis of its anti-thrombotic properties. We aimed to evaluate the efficacy and safety of aspirin in patients admitted to hospital with COVID-19.

Matéria original


The N501Y spike substitution enhances SARS-CoV-2 infection and transmission


Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine